Product Information

FT CHEST CONG RLF DM 400-20 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0779 per EA under NDC 70677105501. Its NADAC has been published 147 times since Sep 6, 2023.

The High Outlier badge above means this manufacturer's average price in the Dextromethorphan Hydrobromide / Guaifenesin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FT CHEST CONG RLF DM 400-20 MG

Dextromethorphan Hydrobromide / Guaifenesin
$0.0779per EA
High Outlier
OTC

Strength

20; 400 mg/1; mg/1

NDC

70677105501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/27/2023

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price Statistics

The NADAC for FT CHEST CONG RLF DM 400-20 MG has been published 147 times since Sep 6, 2023, and over the history we have for it it has declined 4.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0779 per EA
All-time high$0.0831 (Sep 11, 2024)
All-time low$0.0771 (Jun 18, 2025)
52-week high$0.0798
52-week low$0.0771
Median price$0.0790
Average price$0.0796
Largest weekly change+6.3% (May 22, 2024)
Weeks tracked147
Tracking sinceSep 6, 2023

Price History

1W

0.0%

1M

-1.4%

3M

-2.2%

6M

-1.0%

1Y

+0.9%

3Y

N/A

5Y

N/A

All

-4.7%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT CHEST CONG RLF DM 400-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for FT CHEST CONG RLF DM 400-20 MG, manufactured by Strategic Sourcing Services LLC, is $0.0779 per EA (NDC 70677105501), effective Jun 24, 2026.

How has the price of FT CHEST CONG RLF DM 400-20 MG changed over time?

Over the history we have for it, the NADAC for FT CHEST CONG RLF DM 400-20 MG has declined 4.7%. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for FT CHEST CONG RLF DM 400-20 MG?

Since Sep 6, 2023, the NADAC for FT CHEST CONG RLF DM 400-20 MG has ranged from a low of $0.0771 (Jun 18, 2025) to a high of $0.0831 (Sep 11, 2024), with a median of $0.0790 per EA.

Are there cheaper alternatives to FT CHEST CONG RLF DM 400-20 MG?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 2% below FT CHEST CONG RLF DM 400-20 MG.

Who manufactures FT CHEST CONG RLF DM 400-20 MG?

FT CHEST CONG RLF DM 400-20 MG (NDC 70677105501) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.